Clinical Trials on Myelodysplastic Syndrome With Excess Blasts in Germany
Total 215 results
-
University of UlmSunesis PharmaceuticalsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2)Germany
-
Stichting Hemato-Oncologie voor Volwassenen NederlandDeutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Australia, Austria, Belgium, Estonia, Finland, France, Germany, Ireland, Lithuania, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland
-
Stichting Hemato-Oncologie voor Volwassenen NederlandAstellas Pharma Global Development, Inc.; Deutsch-Österreichische Studiengruppe...Active, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Netherlands, Belgium, Germany, Switzerland, Australia, Finland, Norway, Sweden, Austria, France, Ireland, Lithuania, Luxembourg, Spain
-
Onconova Therapeutics, Inc.TerminatedMyelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEBUnited States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Cytopenia | Refractory Anemia With Excess BlastsUnited States, Australia, Spain, Italy, Germany, France, Sweden, Denmark
-
Hannover Medical SchoolUniversity Hospital, Ghent; Johann Wolfgang Goethe University Hospital; University... and other collaboratorsUnknownDe Novo Akute Myeloid Leukemia (AML) | Secondary Acute Myeloid Leukemia (AML) | Refractory Anemia With Excess of Blasts in TransformationGermany
-
Skyline Diagnostics BVIllumina, Inc.TerminatedAcute Myeloid Leukemia (AML) | Acute Promyelocytic Leukemia (APL) | Refractory Anemia With Excess of Blasts (RAEB)United States, Germany, Netherlands, United Kingdom
-
University of UlmRecruitingAcute Myeloid Leukemia (AML) | Higher Risk Myelodysplastic Syndromes (MDS With Excess Blasts 2)Austria, Germany
-
FibroGenAstraZeneca; Astellas Pharma IncTerminatedPrimary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)United States, Australia, Belgium, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, United Kingdom, France, Turkey, Canada, Denmark, India, Poland
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedRecurrent Adult Acute Myeloid Leukemia | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult... and other conditionsUnited States, Germany
-
Assistance Publique - Hôpitaux de ParisImagine Institute; Axonal-Biostatem; CERBA laboratory; SATT; SNC Graft Versus Host...RecruitingAcute Lymphoblastic Leukemia | Acute Myeloid Leukemia in Remission | Lymphoma in Remission | Non-progressive Myeloproliferative Syndrome | Myelodysplasia With Stable Blasts is Cell Number and < 10% of Blastocysts | Acute Leukemia Biphenotypic in RemissionFrance, Germany, Belgium
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Completed
-
University of Erlangen-Nürnberg Medical SchoolNovartis PharmaceuticalsTerminated
-
Genzyme, a Sanofi CompanyTerminatedMyelodysplastic Syndrome (MDS)Germany, United Kingdom, France, Netherlands
-
Heinrich-Heine University, DuesseldorfTerminatedMyelodysplastic Syndrome MDSGermany
-
Apogenix GmbHCompleted
-
Novartis PharmaceuticalsTerminatedMyelodysplastic Syndrome (MDS)Germany
-
AbbVieCelgene; Genentech, Inc.CompletedMyelodysplastic Syndromes (MDS)United States, Australia, Germany
-
European Working Group of MDS in ChildhoodUnknownLeukemia | Myelodysplastic/Myeloproliferative NeoplasmsGermany
-
Institut fuer anwendungsorientierte Forschung und...University Medical Center GoettingenCompletedMyelodysplastic Syndromes (MDS) | Chromosmal Aberrations | Karyotype Evolution | Rare Abnormalities | Cytogenetic MonitoringGermany
-
GWT-TUD GmbHAmsterdam UMC, location VUmc; BerGenBio ASA; Groupe Francophone des MyelodysplasiesCompletedAcute Myeloid Leukemia | High-risk Myelodysplastic Syndrome | Low-risk Myelodysplastic SyndromeGermany, Netherlands, France
-
University of LeipzigNovartis PharmaceuticalsTerminatedMyelodysplastic Syndromes | AnemiaGermany
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Completed
-
Technische Universität DresdenRecruitingMyelodysplastic SyndromesGermany
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndromes (MDS)United States, Australia, Canada, France, Germany, Italy, United Kingdom
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndrome (MDS)France, Spain, Belgium, Italy, Greece, Hungary, Germany
-
Technische Universität DresdenWyeth is now a wholly owned subsidiary of PfizerTerminated
-
iOMEDICO AGCompleted
-
Radboud University Medical CenterRecruitingMyelodysplastic Syndromes (MDS)Denmark, Switzerland, Serbia, Austria, Croatia, Czechia, France, Germany, Greece, Israel, Italy, Netherlands, Poland, Portugal, Romania, Spain, Sweden, United Kingdom
-
GCP-Service International West GmbHSaint-Louis Hospital, Paris, France; University of Florence; Medical University... and other collaboratorsNot yet recruitingLow Risk Myelodysplastic SyndromesSpain, Poland, Italy, Germany, France
-
University Hospital FreiburgActive, not recruitingMyelodysplastic Syndromes | Juvenile Myelomonocytic LeukemiaGermany
-
Istituto Clinico HumanitasUnknownMyelodysplastic SyndromesItaly, Germany, France, Spain
-
Boehringer IngelheimTerminatedMyelodysplastic SyndromesUnited States, Germany
-
Heinrich-Heine University, DuesseldorfCelgene CorporationCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, ChronicGermany
-
Wuerzburg University HospitalCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteGermany
-
University of LeipzigCuris, Inc.TerminatedMyelodysplastic Syndromes | AnemiaGermany
-
Eli Lilly and CompanyCompletedMyelodysplastic SyndromesGermany, Spain, Italy
-
GWT-TUD GmbHCelgeneRecruitingMyelodysplastic SyndromesAustria, Germany, Spain, Switzerland
-
Technische Universität DresdenCompletedMyeloid Leukemia | Myelodysplastic SyndromeGermany
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
GWT-TUD GmbHTerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)France, Germany
-
University of LeipzigCelgene CorporationRecruitingMyelodysplastic Syndromes | AnemiaGermany
-
European Working Group of MDS in ChildhoodUnknownMyelodysplastic Syndromes | LeukemiaGermany, Austria, Switzerland, Czech Republic, Netherlands, Denmark, Belgium, Italy, Poland
-
GCP-Service International West GmbHSaint-Louis Hospital, Paris, France; Groupe Francophone des Myelodysplasies; Australasian... and other collaboratorsRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesAustralia, France, Germany
-
Cell Medica LtdUniversity College, London; Cell Therapy CatapultCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)United Kingdom, Germany, Belgium
-
Boehringer IngelheimTerminatedMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicFrance, Germany
-
CelgeneCompletedMyelodysplastic SyndromeUnited States, Germany
-
European Organisation for Research and Treatment...CompletedMyelodysplastic SyndromesFrance, Belgium, Netherlands, Czech Republic, Italy, Germany
-
Novartis PharmaceuticalsCompletedLow and Int 1-risk Myelodysplastic SyndromeGermany, Canada, Korea, Republic of, Sweden, Spain, China, Argentina, Italy, United Kingdom, Algeria
-
Hoffmann-La RocheTerminatedMyelodysplastic Syndromes, Myelogenous Leukemia, AcuteUnited States, Canada, Germany